Eplivanserin Isomerization via Fumaric Acid and Polar Solvent
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing eplivanserin fail to effectively separate its Z and E isomers, often requiring strong acid or Lewis acid catalysts, and are not scalable for industrial production while avoiding nucleation of the unwanted E isomer.
Innovation Solution
A process involving the use of fumaric acid and a polar solvent with a boiling point greater than 100°C, such as isobutanol, to isomerize and crystallize eplivanserin base, allowing for the isolation of the Z isomer with minimal E isomer contamination and avoiding nucleation, through heating, cooling, inoculation, and filtration steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If strong acid or Lewis acid catalysts are used for isomerization, then the isomerization reaction can proceed, but the process complexity and safety requirements increase
Solution Approach 1:
The patent removes the harmful element (strong acid or Lewis acid catalysts) from the system while maintaining the desired function (isomerization). The isomerization is achieved through thermal energy in polar solvents without requiring catalysts, thus extracting the problematic component while preserving the reaction's effectiveness.
Solution Approach 2:
The system uses the polar solvent and thermal energy to perform the isomerization function that would otherwise require external catalysts. The polar solvent itself facilitates the isomerization process through its dielectric properties and ability to stabilize transition states, making the system self-sufficient without additional catalytic agents.
2Manufacturing precision
If conventional crystallization methods are used, then the Z isomer can be isolated, but the E isomer nucleates and contaminates the product
Solution Approach 1:
The patent changes the physical-chemical parameters of the crystallization process by using polar solvents with specific dielectric constants and controlling temperature profiles. These parameter changes create conditions where the Z isomer crystallizes selectively while the E isomer remains in solution, preventing contamination.
Solution Approach 2:
The polar solvent acts as an intermediary that selectively interacts with the Z and E isomers during crystallization. The solvent's polarity and hydrogen bonding capabilities create a selective environment that favors Z isomer crystallization while keeping the E isomer dissolved, thus mediating the separation process.
3Manufacturing precision
If multiple isolation stages are used to purify the product, then the Z isomer purity increases, but the production time increases
Solution Approach 1:
The patent combines the isomerization and crystallization steps into a single integrated process. By performing isomerization in the polar solvent followed immediately by crystallization in the same medium, the method eliminates intermediate isolation and purification stages, achieving both high purity and time efficiency.
Solution Approach 2:
The process maintains continuous useful action by transitioning directly from isomerization to crystallization without interrupting the reaction mixture. The polar solvent serves both as the reaction medium for isomerization and as the crystallization medium, eliminating time-consuming transfer and intermediate processing steps.
4Productivity
If the process is scaled up for industrial production, then the产量 increases, but the control over isomer separation and nucleation becomes more difficult
Solution Approach 1:
The polar solvent performs multiple functions simultaneously: it acts as the reaction medium for isomerization, as the crystallization medium for selective Z isomer precipitation, and as a means to control nucleation. This multi-functionality simplifies scale-up because the same solvent system works across different production scales without requiring additional reagents or complex process adjustments.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves a high yield of greater than 99.5% Z isomer with less than 0.5% E isomer, doubling the theoretical yield and enabling large-scale industrial production while avoiding nucleation of the E isomer.
Implementation Method 1
the eplivanserin base is isomerized and crystallized, by the action of fumaric acid
Implementation Method 2
crystallized, by the action of fumaric acid, in the presence of a polar solvent whose boiling point is greater than 100° C.
Implementation Method 3
the mixture is heated to 105°C, which ensures that the isomerization equilibrium is reached, then cooled to 100°C
Implementation Method 4
then cooled in stages to the filtration temperature
Data Source
AI summary
Method for preparing eplivanserin hemifumarate.